Alice Lin
Dr Ken Baker
| Aetiopathology of rheumatoid arthritis | 2025 |
|
Dr Fiona Rayner
Shaun Hiu
Dr Theophile Bigirumurame
Dr Amy Anderson
Jon Prichard
et al. | Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study | 2025 |
|
Dr Ken Baker
| Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation | 2025 |
|
Dr Ken Baker
Professor Iain McInnes
| Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration | 2025 |
|
Dr Javad Sarvestan
Dr Ken Baker
Dr Silvia Del Din
| Exploring the Effect of Sampling Frequency on Real-World Mobility, Sedentary Behaviour, Physical Activity and Sleep Outcomes Measured with Wearable Devices in Rheumatoid Arthritis: Feasibility, Usability and Practical Considerations | 2025 |
|
Mx Nana Aboagye
Maria Germann
Dr Ken Baker
Professor Mark Baker
Dr Silvia Del Din
| Feasibility of Predicting Next-Day Fatigue Levels Using Heart Rate Variability and Activity-Sleep Metrics in People with Post-COVID Fatigue. | 2025 |
|
Dr Leher Gumber
Dr Fiona Rayner
Dr Theophile Bigirumurame
Dr Bernard Dyke
Sean Kerrigan
et al. | Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis | 2025 |
|
Mx Nana Aboagye
Dr Chloe Hinchliffe
Professor Fai Ng
Dr Silvia Del Din
Dr Ken Baker
et al. | Systematic Review: Digital Biomarkers of Fatigue in Chronic Diseases | 2025 |
|
Dr Ken Baker
Dr David McDonald
Dr Gill Hulme
Raf Hussain
Dr Jonathan Coxhead
et al. | Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission | 2024 |
|
Dr Domenico Somma
Professor John Isaacs
Professor Andrew Filby
Dr David McDonald
Dr Jasmine Sim
et al. | Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis | 2024 |
|
Alice Lin
Dr Josh Bennett
Dr Ewan Hunter
Dr Alice Lorenzi
Dr Bridget Griffiths
et al. | COVID-19 antiviral therapy for non-hospitalised immunosuppressed patients with rheumatic diseases is feasible with positive outcomes | 2023 |
|
Emily Hunter
Professor Anthony De Soyza
Dr Rachel Agbeko
Dr Ken Baker
Dr Quentin Campbell Hewson
et al. | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | 2022 |
|
Dr Nikolaos Vlachogiannis
Dr Ken Baker
Dr Georgios Georgiopoulos
Dr Ina Schim van der Loeff
Dr Aidan Hanrath
et al. | Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort study | 2022 |
|
Dr Ken Baker
Dr Dennis Lendrem
Adam Scadeng
Dr Ben Thompson
Dr Arthur Pratt
et al. | Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298 | 2022 |
|
Dr Ken Baker
Dr Christopher Duncan
Dr Suzanne Elcombe
Professor Andrew Gennery
| Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK | 2022 |
|
